In this study replication of A-type and B-type Epstein-Barr virus (EBV) strains has been assessed. A-type and B-type type lymphoblastoid cell lines (LCLs) were established by infecting B lymphocytes, isolated from five EBV-seropositive donors, with different A-type and B-type virus isolates. The presence of viral capsid antigens (VCA) in these LCLs was determined by immunofluoresence assay and by immunoblotting. All of the B-type EBV strains were capable of spontaneously generating virus regardless of the origin of the donor cells. In contrast the A-type strains, other than strain IARC-BL36, did not readily produce VCA in any of the different donor lymphocytes used. This study demonstrates another biological difference between the two virus types: their ability to spontaneously enter the lytic cycle.
AdldingerH. K.,
DeliusH.,
FreeseU. K.,
ClarkeJ.,
BornkammG. W.1985; A putative transforming gene of Jijoye virus differs from that of Epstein–Barr virus prototypes. Virology 141:221–234
ArrandJ. R.,
YoungL. S.,
TugwoodJ. D.1989; Two families of sequences in the small RNA-encoding region of Epstein–Barr virus (EBV) correlate with EBV types A and B. Journal of Virology 63:983–986
BurnetteW.N.1981; ‘Western Blotting’: electrophoretic transfer of proteins from SDS-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Analytical Biochemistry 112:195–203
CountrymanJ.,
JensonH.,
SeiblR.,
WolfH.,
MillerG.1987; Polymorphic proteins encoded within BZLF1 of defective and standard Epstein–Barr viruses disrupt latency. Journal of Virology 61:3672–3679
DambaughT.,
HennessyK.,
ChamnankitL.,
KieffE.1984; U2region of Epstein–Barr virus DNA may encode Epstein–Barr nuclear antigen 2. Proceedings of the National Academy of Sciences, USA 81:7632–7636
GutierrezM. I.,
BhatiaK.,
MagrathI.1993; Replicative viral DNA in Epstein–Barr virus associated Burkitt’s lymphoma biopsies. Leukemia Research 17:285–289
HenleW.,
HenleG.,
ZajacB. A.,
PearsonG.,
WaubkeR.,
ScribaM.1970; Differential reactivity of human serums with early antigens induced by Epstein–Barr virus. Science 169:188–190
JensonH. B.,
MillerG.1987; Sequences of the Epstein–Barr Virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA. Journal of Virology 61:1495–1506
KyawM. T.,
HurrenL.,
EvensL.,
MossD. J.,
CooperD. A.,
BensonE.,
SculleyT. B.1992; Expression of B-type Epstein–Barr virus inHIV-infected patients and cardiac transplant recipients. AIDS Research 8:1869–1874
MillerG.,
LipmanM.1973; Release of infectious Epstein–Barr virus by transformed marmoset leukocytes. Proceedings of the National Academy of Sciences, USA 70:190–194
RickinsonA. B.,
YoungL. S.,
RoweM.1987; Influence of the Epstein–Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. Journal of Virology 61:1310–1317
SampleJ.,
HummelM.,
BraunD.,
BirkenbachM.,
KieffE.1986; Nucleotide sequences of mRNAs encoding Epstein–Barr virus nuclear proteins. A probable transcriptional initiation site. Proceedings of the National Academy of Sciences, USA 83:5096–5100
SampleJ.,
YoungL.,
MartinB.,
ChatmanT.,
KieffE.1990; Epstein–Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. Journal of Virology 64:4084–4092
SculleyT. B.,
MossD. J.,
HazeltonR. A.,
PopeJ. H.1987; Detection of Epstein–Barr virus strain variants in lymphoblastoid cell lines ‘spontaneously’ derived from patients with rheumatoid arthritis, infectious mononucleosis and normal controls. Journal of General Virology 68:2069–2078
SculleyT. B.,
CrossS. M.,
BorrowP.,
CooperD. A.1988; Prevalence of antibodies to Epstein–Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus. Journal of Infectious Diseases 158:186–192
SculleyT. B.,
ApolloniA.,
HurrenL.,
MossD. J.,
CooperD. A.1990; Coinfection with A- and B-type Epstein–Barr virus in human immunodeficiency virus-positive subjects. Journal of Infectious Diseases 162:643–648
SerioT. R.,
AngeloniA.,
KolmanJ. L.,
GradovilleL.,
SunR.,
KatzD. A.,
Van GrunsvenW.,
MiddeldorpJ.,
MillerG.1996; Two 21-kilodalton components of the Epstein–Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21). Journal of Virology 70:8047–8054
WallingD. M.,
EdmistonS. N.,
SixbeyJ. W.,
Abdel-HamidM.,
ResnickL.,
Raab-TraubN.1992; Coinfection with multiple strains of the Epstein–Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proceedings of the National Academy of Sciences, USA 89:6560–6564
YoungL. S.,
YaoQ. Y.,
RooneyC. M.,
SculleyT. B.,
MossD. J.,
RupaniH.,
LauxG.,
BornkammG. W.,
RickinsonA. B.1987; New type B isolates of Epstein–Barr virus from Burkitt’s lymphoma and from normal individuals in endemic areas. Journal of General Virology 68:2853–2862
ZimberU.,
AldingerH. K.,
LenoirG. M.,
VuillaumeM.,
Knebel-DoerberitzM. G.,
LauxG.,
DesgrangesC.,
WittmanP.,
BornkammG. W.1986; Geographical prevalence of two types of Epstein–Barr virus. Virology 154:56–66